Migraines in childhood as a cause of headache in adulthood – how to prevent it? A literature review
More details
Hide details
Medical University, Lublin, Poland
Corresponding author
Aleksandra Ziółkiewicz   

Medical University, Lublin, Poland.
J Pre Clin Clin Res. 2024;1(18):74-82
Introduction and objective:
Migraine is the most common acute and recurrent headache in children. The pain is the result of stimulation of meningeal nociceptors. There may be a genetic predisposition to generalized neuronal hyperexcitability. Aura is caused by the cortical spreading depression (CSD).Migraines hamper daily functioning and cause adverse effects in future adult life. This review aims to introduce the most common forms and present their diagnosis and treatment methods.

Review methods:
The following electronic databases were searched: Pubmed, Google Scholar using the keywords ‘childhood migraine disorder’, ‘paediatric migraine’, ‘migraine in children’. Articles in English were included.

Brief description of the state of knowledge:
The review shows both the diagnostic modalities of migraines and the latest methods of treating and preventing migraines from developing.

In the diagnosis of migraine in paediatric patients, particular importance is attached to a thorough clinical history. Paediatric patients suffering from migraine have a reduced density of grey matter in the frontal cortex. In the therapeutic process a multi-media approach, including lifestyle changes, psychoeducation and psychotherapy and pharmacotherapy, are important.

There is a good response to OCT analgesics in children and adolescents. There are reports in the literature that migraine occurring in children becomes a risk factor for migraines in adults. Migraines in children represent a difficult disease entity, both diagnostically and therapeutically. To-date, no significant changes have been demonstrated on imaging studies in children and the symptoms themselves may be uncharacteristic. Further research is needed to consider and implement the use of new drugs.

Ziółkiewicz A, Jartych A, Iwanicka K, Chawrylak K, Zegardło W, Szukała K, Chrościńska-Krawczyk M. Migraines in childhood as a cause of headache in adulthood – how to prevent it? A literature review. J Pre-Clin Clin Res. 2024; 19(1): 74–82. doi: 10.26444/jpccr/181524
Dodick DW. Migraine. Lancet. 2018 Mar 31;391(10127):1315–1330.
Abu-Arafeh I, Gelfand AA. The childhood migraine syndrome. Nat Rev Neurol. 2021 Jul;17(7):449–458.
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1–211.
Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019 Nov;37(4):631–649.
Al Khalili Y, Asuncion RMD, Chopra P. Migraine Headache in Childhood. 2023 Mar 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 32491745.
Raieli V, D’Amico A, Piro E. Migraine in Children Under 7 Years of Age: a Review. Curr Pain Headache Rep. 2020 Dec 16;24(12):79.
Ursitti F, Valeriani M. Migraine in childhood: Gender differences. Eur J Paediatr Neurol. 2023 Jan;42:122–125.
Youssef PE, Mack KJ. Episodic and chronic migraine in children. Dev Med Child Neurol. 2020 Jan;62(1):34–41.
Arruda MA, Bigal ME. Migraine and migraine subtypes in preadolescent children: association with school performance. Neurology. 2012 Oct 30;79(18):1881–8.
Guidetti V, Cerutti R, Faedda N, Natalucci G. Migraine in childhood: an organic, biobehavioral, or psychosomatic disorder? Neurol Sci. 2019 May;40(Suppl 1):93–98.
Straube A, Heinen F, Ebinger F, et all. Headache in school children: prevalence and risk factors. Dtsch Arztebl Int. 2013 Nov 29;110(48):811–8.
Lagman-Bartolome AM, Lay C. Pediatric migraine variants: a review of epidemiology, diagnosis, treatment, and outcome. Curr Neurol Neurosci Rep. 2015 Jun;15(6):34.
Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain. 2013 Dec;154 Suppl 1:S44–53.
Ferrari MD, Klever RR, Terwindt GM, et al. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol. 2015 Jan;14(1):65–80.
Winner P, Linder S, Hershey AD. Consistency of response to sumatriptan/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence. Headache 2015;55:519–528.
Maniyar FH, Sprenger T, Monteith T, et al. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2014 Jan;137(Pt 1):232–41.
Shechter A, Stewart WF, Silberstein SD, Lipton RB. Migraine and autonomic nervous system function: a population-based, case-control study. Neurology. 2002 Feb 12;58(3):422–7.
Noseda R, Kainz V, Borsook D, Burstein R. Neurochemical pathways that converge on thalamic trigeminovascular neurons: potential substrate for modulation of migraine by sleep, food intake, stress and anxiety. PLoS One. 2014 Aug 4;9(8):e103929.
Borsook D, Maleki N, Becerra L, McEwen B. Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load. Neuron. 2012 Jan 26;73(2):219–34.
Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4687–92.
Lippman CW. Certain hallucinations peculiar to migraine. J Nerv Ment Dis. 1952 Oct;116(4):346–51.
Basedau H, Sturm LM, Mehnert J, et al. Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target – an fMRI study. Elife. 2022 May 23;11:e77146.
Edvinsson L, Haanes KA, Warfvinge K, et al. CGRP as the target of new migraine therapies – successful translation from bench to clinic. Nat Rev Neurol. 2018 Jun;14(6):338–350.
Zhang Q, Han X, Wu H, et al. Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine. Mol Pain. 2019 Jan-Dec;15:1744806918820452.
Johansson SE, Abdolalizadeh B, Sheykhzade M, et al. Vascular pathology of large cerebral arteries in experimental subarachnoid hemorrhage: Vasoconstriction, functional CGRP depletion and maintained CGRP sensitivity. Eur J Pharmacol. 2019 Mar 5;846:109–118.
Basedau H, Oppermann T, Gundelwein Silva E, et al. Characterization of trigeminal C-fiber reactivity through capsaicin-induced release of calcitonin gene-related peptide. Headache. 2023 Mar;63(3):353–359.
Nowaczewska M, Straburzyński M, Waliszewska-Prosół M, et al. Cerebral Blood Flow and Other Predictors of Responsiveness to Erenumab and Fremanezumab in Migraine-A Real-Life Study. Front Neurol. 2022 May 17;13:895476.
Mulder IA, Li M, de Vries T, et al. Anti-migraine Calcitonin Gene-Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice. Ann Neurol. 2020 Oct;88(4):771–784.
Giani L, Proietti Cecchini A, Leone M. Anti-CGRP in cluster headache therapy. Neurol Sci. 2019 May;40(Suppl 1):129–135.
Nisar A, Ahmed Z, Yuan H. Novel Therapeutic Targets for Migraine. Biomedicines. 2023 Feb 15;11(2):569.
Brumm K, Walenski M, Haist F, et al. Functional magnetic resonance imaging of a child with Alice in Wonderland syndrome during an episode of micropsia. J AAPOS. 2010 Aug;14(4):317–22.
Gencoglu EA, Alehan F, Erol I, et al. Brain SPECT findings in a patient with Alice in Wonderland syndrome. Clin Nucl Med. 2005 Nov;30(11):758–9.
Morland D, Wolff V, Dietemann JL, et al. Robin Hood caught in Wonderland: brain SPECT findings. Clin Nucl Med. 2013 Dec;38(12):979–81.
Sampaio Rocha-Filho PA, Gherpelli JLD. Premonitory and Accompanying Symptoms in Childhood Migraine. Curr Pain Headache Rep 2022;26:151–163.
Cuvellier JC, Mars A, Vallée L. The prevalence of premonitory symptoms in paediatric migraine: a questionnaire study in 103 children and adolescents. Cephalalgia. 2009;29:1197–201.
Karsan N, Prabhakar P, Goadsby PJ. Characterising the premonitory stage of migraine in children: a clinic-based study of 100 patients in a specialist headache service. J Headache Pain. 2016;17:94.
Petrusic I, Pavlovski V, Vucinic D, et al. Features of migraine aura in teenagers. J Headache Pain 2014;15:87.
Ahmed M, Boyd C, Vavilikolanu R, et al. Visual symptoms and childhood migraine: Qualitative analysis of duration, location, spread, mobility, colour and pattern. Cephalalgia. 2018;38:2017–25.
Blom JD. Alice in Wonderland syndrome: A systematic review. Neurol Clin Pract. 2016 Jun;6(3):259–270.
Genizi J, Khourieh Matar A, Zelnik N, et al. Frequency of pediatric migraine with aura in a clinic-based sample. Headache. 2016 Jan;56(1):113–7.
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1–212.
Li BU. Managing cyclic vomiting syndrome in children: beyond the guidelines. Eur J Pediatr. 2018 Oct;177(10):1435–1442.
Mamouri O, Cuvellier JC, Duhamel A, et al. Postdrome symptoms in pediatric migraine: a questionnaire retrospective study by phone in 100 patients. Cephalalgia. 2018;38:943–8.
Gelfand AA. Episodic syndromes that may be associated with migraine: a.k.a. “the childhood periodic syndromes”. Headache. 2015;55(10):1358–64.
Rothner AD, Parikh S. Headache currents: migraine variants or episodic syndromes that may be associated with migraine and other unusual pediatric headache syndromes. Headache. 2015;56(1):206–14.
Sabino L, Marino S, Falsaperla R, et al. Celiac disease and headache in children: a narrative state of the art. Acta Biomed. 2020 Sep 7;91(3):e2020056.
Miller JA, Missmer SA, Vitonis AF, et al. Prevalence of migraines in adolescents with endometriosis. Fertil Steril. 2018 Apr;109(4):685–690.
Walter SM, Dai Z, Wang K. Obesity, Migraine, and Overlapping Comorbidities in a Rural Pediatric Population. J Neurosci Rural Pract. 2021 Jul;12(3):524–529.
Zhao YJ, Lim JY, Wong PS. Diagnosis and Management of Headaches in the Emergency Department (ED) in Adults and Children. Neurol India 2021;69, Suppl S1:173–82.
Eigenbrodt AK, Ashina H, Khan S, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17(8): 501–514.
de Tommaso M. An update on EEG in migraine. Expert Rev Neurother. 2019 Aug;19(8):729–737.
Webb ME, Amoozegar F, Harris AD. Magnetic Resonance Imaging in Pediatric Migraine. Canad J Neurol Sci. 2019;46(6):653–665.
Koch T, Oakley CB. Pediatric migraine: Diagnostic criteria and treatment. Contemp. Pediatr. June 2018;35(6):22.
Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: Acute treatment of migraine in children and adolescents, Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. Sep 2019;93(11):487–499. doi:10.1212/WNL.0000000000008095.
O’Brien H, Kabbouche MA, Kacperski J, et al. Treatment of Pediatric Migraine. Curr Treat Options Neurol. 2015;17(1).
Gross EC, Lisicki M, Fischer D, et al. The metabolic face of migraine – from pathophysiology to treatment. Nat Rev Neurol. 2019 Nov;15(11):627–643.
Powers SW, Coffey CS, Chamberlin LA, et al. Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. N Engl J Med. 2017 Jan 12;376(2):115–124.
Powers SW, Kashikar-Zuck SM, Allen JR, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA 2013;310:2622–2630.
Amanat M, Togha M, Agah E, et al. Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial. Cephalalgia. 2020;40(7):665–674.
Borner C, Urban G, Beaulieu LD, et al. The bottom-up approach: Non-invasive peripheral neurostimulation methods to treat migraine: A scoping review from the child neurologist’s perspective. Eur J Pediatr Neurol. 2021;32:16–28.
Papetti L, Sforza G, Tullo G, et al. Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study. Pain Res Manag. 2020 Apr 24;2020:3938640.
Edvinsson L. Role of CGRP in Migraine. Handb Exp Pharmacol. 2019;255:121–130.
Negro A, Martelletti P. Gepants for the treatment of migraine. Expert Opin Investig Drugs. 2019 Jun;28(6):555–567.
Dodick DW, Lipton RB, Ailani J, et al. Ubrogepant for the Treatment of Migraine. N Engl J Med. 2019 Dec 5;381(23):2230–2241.
Croop R, Goadsby PJ, Stock DA, et al. Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. Lancet. 2019 Aug 31;394(10200):737–745.
Szperka CL, VanderPluym J, Orr SL, et al. Recommendations on the use of anti-CGRP monoclonal antibodies in children and adolescents. Headache. 2018;58(10):1658–69.
Marshall A, Lindsay R, Clementi MA, et al. Outpatient Approach to Resistant and Refractory Migraine in Children and Adolescents: a Narrative Review. Curr Neurol Neurosci Rep. 2022;22:611–624.
Esparham A, Stark-Inbar A, Jekel L, et al. Acute Treatment of Migraine in Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN). Pediatr Neurol. 2023;142:51–55
Barbanti P, Fofi L, Aurili C, et al. Ketogenic diet in migraine: rationale, findings and perspectives. Neurol Sci. 2017; 38 (Suppl 1):111–115.
Tarantino S, Papetti L, Di Stefano A, et al. Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine. Front Psychol. 2020 Oct 28;11:530911.
Papetti L, Moavero R, Ferilli MAN, et al. Truths and Myths in Pediatric Migraine and Nutrition. Nutrients. 2021;13(8):2714.
Papetti L, Salfa I, Battan B, et al. Features of Primary Chronic Headache in Children and Adolescents and Validity of Ichd 3 Criteria. Front Neurol. 2019 Feb 15;10:92.
Viticchi G, Falsetti L, Paolucci M, et al. Influence of chronotype on migraine characteristics. Neurol Sci. 2019 Sep;40(9):1841–1848.
Amin FM, Aristeidou S, Baraldi C, et al. European Headache Federation School of Advanced Studies (EHF-SAS). The association between migraine and physical exercise. J Headache Pain. 2018 Sep 10;19(1):83.
Hindiyeh NA, Zhang N, Farrar M, et al. The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review. Headache. 2020 Jul;60(7):1300–1316.
Minen MT, Begasse De Dhaem O, et al. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):741–9.
Garnefski N, van Rood Y, de Roos C, et al. Relationships Between Traumatic Life Events, Cognitive Emotion Regulation Strategies, and Somatic Complaints. J Clin Psychol Med Settings. 2017 Jun;24(2):144–151.
Afifi TO, MacMillan HL, Boyle M, et al. Child abuse and physical health in adulthood. Health Rep. 2016 Mar 16;27(3):10–8. PMID: 26983007.
Tietjen GE, Karmakar M, Amialchuk AA. Emotional Abuse History and Migraine Among Young Adults: A Retrospective Cross-Sectional Analysis of the Add Health Dataset. Headache. 2017 Jan;57(1):45–59.
Bhurat R, Premkumar S, Manokaran RK. Serum Magnesium Levels in Children With and Without Migraine: A Cross-Sectional Study. Indian Pediatr. 2022 Aug 15;59(8):623–625. PMID: 35751375.
Liao CC, Chien CH, Shih YH, et al. Acupuncture Is Effective at Reducing the Risk of Stroke in Patients with Migraines: A Real-World, Large-Scale Cohort Study with 19-Years of Follow-Up. Int J Environ Res Public Health. 2023 Jan 17;20(3):1690.
Journals System - logo
Scroll to top